Cargando…
Pilot Study of Sentinel-Node-Based Adoptive Immunotherapy in Advanced Colorectal Cancer
BACKGROUND: Despite optimal surgical treatment and modern adjuvant therapies, 50% of patients diagnosed with colorectal cancer die within 5 years. Immunotherapy offers an appealing complement to traditional chemotherapy, with possible long-term protection against tumor recurrences through immunologi...
Autores principales: | Karlsson, Mona, Marits, Per, Dahl, Kjell, Dagöö, Tobias, Enerbäck, Sven, Thörn, Magnus, Winqvist, Ola |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2889279/ https://www.ncbi.nlm.nih.gov/pubmed/20119674 http://dx.doi.org/10.1245/s10434-010-0920-8 |
Ejemplares similares
-
Metinel Node—The First Lymph Node Draining a Metastasis—Contains Tumor-Reactive Lymphocytes
por: Dahl, Kjell, et al.
Publicado: (2008) -
Sentinel node lymphocytes: tumour reactive lymphocytes identified intraoperatively for the use in immunotherapy of colon cancer
por: Marits, P, et al.
Publicado: (2006) -
Clinical Translation of Ex Vivo Sentinel Lymph Node Mapping for Colorectal Cancer Using Invisible Near-Infrared Fluorescence Light
por: Hutteman, Merlijn, et al.
Publicado: (2010) -
Limited Value of Staging Squamous Cell Carcinoma of the Anal Margin and Canal Using the Sentinel Lymph Node Procedure: A Prospective Study with Long-Term Follow-Up
por: de Jong, Johannes S., et al.
Publicado: (2010) -
Treatment of Inguinal Lymph Node Metastases in Patients with Rectal Adenocarcinoma
por: Hagemans, J. A. W., et al.
Publicado: (2019)